What's breaking now, across thousands of outlets.
(RTTNews) - Eli Lilly and Company (LLY) reported detailed Phase 3 TRIUMPH-2 results showing that Retatrutide delivered substantial weight loss and blood sugar reductions in adults with obesity or overweight and type 2 diabetes.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The initiative aims to take early diagnosis, genetic counselling, and specialised treatment to remote tribal pockets that carry a disproportionate burden of the genetic blood disorder.
Thriving Kids is available to all children experiencing developmental delays, with the first phase of its roll-out beginning on October 1.
[Health-e] Stress, fatigue and poor sleep can influence what foods you crave. Persistent cravings can contribute to unhealthy eating patterns. Recognising your triggers can help you manage cravings.
[Nyasa Times] Malawi is on the brink of a major breakthrough in the fight against cancer, with advanced diagnosis and treatment facilities known as nuclear medicine set to launch in Lilongwe…
Will Reeve said he was inspired to share his story after watching his parents, the late Christopher Reeve and Dana Reeve, "take the adversity they faced in their lives and repurpose it into something…
